GraniteShares Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,109	Closed	-$1.17M	–	118
2024 Q3	$1.17M	Sell	1,109 -121	-10%	-$135K	0.79%	55
2024 Q2	$1.29M	Buy	1,230 +102	+9%	+$98.9K	0.43%	55
2024 Q1	$1.09M	Sell	1,128 -9	-0.8%	-$8.56K	0.57%	59
2023 Q4	$999K	Sell	1,137 -176	-13%	-$145K	0.9%	56
2023 Q3	$1.08M	Buy	1,313 +1,004	+325%	+$789K	1.01%	51
2023 Q2	$222K	Sell	309 -21	-6%	-$16.2K	0.2%	100
2023 Q1	$271K	Sell	330 -8	-2%	-$6.03K	0.24%	100
2022 Q4	$244K	Sell	338 -57	-14%	-$42.1K	0.2%	128
2022 Q3	$272K	Sell	395 -54	-12%	-$34K	0.22%	111
2022 Q2	$265K	Sell	449 -13	-3%	-$8.45K	0.19%	118
2022 Q1	$322K	Sell	462 -49	-10%	-$31K	0.17%	130
2021 Q4	$322K	Buy	+511	New	+$314K	0.15%	139